Tennessee and several other states have opened pathways for immigrants with US-level equivalent medical practice and licensing to practice in the US without having to go back through medical training. In some cases, barriers have been thrown up at the licensing level by the state medical boards, and in others, there are still huge (and sometimes expensive) visa and US residency barriers to overcome. IMGs are significantly more likely to enter primary care and primary care practices, but behind the practice pathways, political battles are still taking place to raise barriers.
Need More Primary Care Physicians? Rethink how International Medical Grads are Handled - Medical Economics
The Perverse Consequences of Tuition-Free Medical SchoolAtlantic article examining whether tuition-free medical school has impacted the number of physicians entering primary care, improved minority representation, or improved the level of “financially disadvantaged”. Examining NYU in particular, but including other schools where donations have allowed them to go tuition free, the results after seven years of programs are exactly the opposite of the intent. Which doesn’t mean the programs are bad, but that the work towards becoming a physician begins long before medical school, and the admissions criteria or cost doesn’t magically change who enrolls. The Perverse Consequences of Tuition-Free Medical School - Atlantic Zoom to Use AI for Medical Notes During Telehealth Doctor VisitsZoom has a HIPAA compliant offering, and is working with Suki, the popular note-transcription service for clinicians to generate clinical notes from telehealth visits. Zoom has a native transcription service as well, which does a pretty great job of meeting summarization. If you think that real-time voice recognition is still stuck back at the Siri and Alexa days, you should try some of the new AI systems. Zoom to use AI for Medical Notes during Telehealth Doctor Visits - Fast Company EviCore, the Company Helping U.S. Health Insurers Deny Coverage for TreatmentsProPublica is known for in-depth investigative reports, often done in collaboration with other news organizations. In this case, we haven’t seen a lot of syndication of the article. EviCore (a Cigna company) manages prior authorization for insurers representing around 100 million insured, as well as oncology and pharmacy approvals. Being a company pretty specifically designed to say “No” isn’t going to make them very popular, but the article adequately explains both sides of the transaction. What everyone wants to know about businesses like this are the decision-making criteria. That’s where it gets murky. EviCore, the Company Helping U.S. Health Insurers Deny Coverage for Treatments - ProPublica |